MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
1992 |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
24.6 M |
Market Cap[1] |
$ 4 B |
EBITDA (LTM) |
$ 244 M |
P/E (LTM) |
5586.0 |
P/S (LTM) |
1.850599 |
EPS (LTM) |
0.03 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Microbot Medical
MBOT
|
$ 1.47 | 1.74 % | $ 67.3 M | Nasdaq Global Select Market |  Israel |
 |
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | USA |
 |
Merit Medical Systems
MMSI
|
$ 86.72 | 1.16 % | $ 5.13 B | Nasdaq Global Select Market,SPB | USA |
 |
Nephros
NEPH
|
$ 4.18 | 2.96 % | $ 44.4 M | Nasdaq Global Select Market | USA |
 |
Envista Holdings Corporation
NVST
|
$ 26.79 | 0.73 % | $ 4.5 B | NYSE | USA |
 |
OraSure Technologies
OSUR
|
$ 3.42 | 2.27 % | $ 251 M | Nasdaq Global Select Market,SPB | USA |
 |
Pro-Dex
PDEX
|
$ 69.45 | 18.88 % | $ 224 B | Nasdaq Global Select Market | USA |
 |
Pulse Biosciences
PLSE
|
$ 48.58 | 3.85 % | $ 3.27 B | Nasdaq Global Select Market | USA |
 |
ResMed
RMD
|
$ 222.41 | 0.04 % | $ 32.4 B | NYSE,SPB | USA |
 |
STAAR Surgical Company
STAA
|
$ 23.85 | 1.62 % | $ 1.18 B | Nasdaq Global Market,SPB | USA |
 |
Stereotaxis
STXS
|
$ 1.34 | 0.36 % | $ 122 M | NYSE American | USA |
 |
Teleflex Incorporated
TFX
|
$ 135.83 | 0.38 % | $ 6.06 B | NYSE,SPB | USA |
 |
Utah Medical Products
UTMD
|
$ 69.5 | 0.55 % | $ 225 M | Nasdaq Global Select Market | USA |
 |
West Pharmaceutical Services
WST
|
$ 334.81 | 0.03 % | $ 24.2 B | NYSE,SPB | USA |
 |
DENTSPLY SIRONA
XRAY
|
$ 11.07 | 0.48 % | $ 2.21 B | Nasdaq Global Select Market,SPB | USA |
 |
Retractable Technologies
RVP
|
$ 0.73 | 2.12 % | $ 21.9 M | NYSE American | USA |
 |
AngioDynamics
ANGO
|
$ 15.21 | 0.07 % | $ 632 M | Nasdaq Global Select Market | USA |
 |
Becton, Dickinson and Company
BDX
|
$ 179.95 | 0.05 % | $ 51.8 B | NYSE,SPB | USA |
 |
The Cooper Companies
COO
|
$ 67.68 | 1.31 % | $ 13.5 B | NYSE,SPB | USA |
 |
electroCore
ECOR
|
$ 9.03 | 1.1 % | $ 76.6 K | Nasdaq Global Select Market | USA |
 |
Glaukos Corporation
GKOS
|
$ 179.91 | 1.3 % | $ 10.3 B | NYSE,SPB | USA |
 |
Haemonetics Corporation
HAE
|
$ 101.64 | 0.07 % | $ 4.8 B | NYSE,SPB | USA |
 |
Harvard Bioscience
HBIO
|
$ 7.95 | 0.25 % | $ 353 M | Nasdaq Global Market | USA |
 |
AtriCure
ATRC
|
$ 52.04 | 1.01 % | $ 2.48 B | Nasdaq Global Market,SPB | USA |
 |
InfuSystem Holdings
INFU
|
$ 11.98 | 0.74 % | $ 247 M | NYSE American | USA |
 |
Repro Med Systems
KRMD
|
$ 3.13 | 0.93 % | $ 145 M | Nasdaq Capital Market | USA |
 |
LeMaitre Vascular
LMAT
|
$ 79.64 | 0.22 % | $ 1.8 B | Nasdaq Global Market,SPB | USA |
 |
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | USA |
 |
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | USA |
 |
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | USA |
 |
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | USA |
 |
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | USA |
 |
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | USA |
 |
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | USA |
 |
Alcon
ALC
|
$ 69.09 | 0.3 % | $ 34.1 B | NYSE |  Schweiz |
 |
Baxter International
BAX
|
$ 24.98 | 1.02 % | $ 12.8 B | NYSE,SPB | USA |
 |
BioLife Solutions
BLFS
|
$ 35.69 | 1.23 % | $ 1.7 B | Nasdaq Global Select Market | USA |
 |
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | USA |
 |
iRhythm Technologies
IRTC
|
$ 120.8 | 0.77 % | $ 3.87 B | Nasdaq Global Select Market,SPB | USA |
 |
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | USA |
 |
Intuitive Surgical
ISRG
|
$ 353.44 | 0.28 % | $ 126 B | Nasdaq Global Select Market,SPB | USA |
 |
Masimo Corporation
MASI
|
- | - | $ 9.59 B | Nasdaq Global Select Market,SPB | USA |
 |
Milestone Scientific
MLSS
|
$ 0.46 | 0.06 % | $ 37.7 M | NYSE American | USA |
 |
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | USA |
 |
Repligen Corporation
RGEN
|
$ 170.51 | 1.74 % | $ 9.59 M | Nasdaq Global Select Market,SPB | USA |
 |
STERIS plc
STE
|
$ 219.9 | 0.31 % | $ 21.6 B | NYSE,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.